International Long-term Follow-up Study of Patients Implanted With a Portico™ Valve (PORTICO-1)
the PORTICO-1 study is an international clinical observation study that followed patients who received Portico™ TAVI System valve implants following severe symptomatic aortic stenosis. The study was conducted at 65 medical centres across 13 countries. A total of 941 participants were recruited into the trial and followed up to investigate treatment outcomes, including all-cause mortality, cardiovascular mortality, myocardial infarction, and stroke. The average age of participants was 82.4 years and 65.7% were female.
Study design
Cohort - clinical
Number of participants at first data collection
941 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2013
Primary Institutions
Institut Universitaire De Cardiologie Et De Pneumologie de Québec (ICUPQ)
Rigshopitalet University Hospital
San Raffaele Hospital (San Raffaele Ospedale)
St Andrews Hospital
University Hospital Zurich (Universitätsspital Zürich, USZ)
Profile paper DOI
Funders
Abbott
Ongoing?
No
Data types collected
Quantitative data collection
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-report questionnaire – paper or computer assisted
Qualitative data collection
- None
Neuroimaging data collection
- None
Linked or secondary data
- None
Engagement
Keywords
